Save 75% - Only $49.99 for 1 full year! digitalPLUS subscription offer ends 12/1

Topics

U.S. Department of Health and Human Services
HHS investing $5.8M in Ebola vaccine Baltimore company Profectus is developing
HHS investing $5.8M in Ebola vaccine Baltimore company Profectus is developing

An arm of the U.S. Department of Health and Human Services is giving $5.8 million to Baltimore company Profectus BioSciences for its efforts to develop an Ebola vaccine. The investment comes as the southeast Baltimore biotechnology company prepares to apply to the Food and Drug Administration to begin human clinical trials. The money from HHS's Biomedical Advanced Research and Development Authority will go toward manufacturing a vaccine for those trials, Profectus President Jeffrey Meshulam said. The vaccine candidate is one of many that is advancing rapidly as health officials seek to contain an Ebola outbreak that continues to grow. Given that just a few thousand people had died...

Loading